Shannon Tokheim , Associate Editor at MarketBeat Articles Reviewed by Shannon Tokheim - Page 13October 14, 2024 7:33 AM ETHewlett Packard Enterprises: 4 Reasons to Get In Now on the StockJea YuHewlett Packard Enterprise Co. (NYSE: HPE) is a global technology company focused on providing edge-to-cloud solutions for businesses and organizations.NYSE:HPENYSE:JNPRNASDAQ:AMDRead Hewlett Packard Enterprises: 4 Reasons to Get In Now on the StockOctober 14, 2024 7:23 AM ETDelta Air Lines: 3 Reasons This Dip Is Too Good to MissJea YuDelta Air Lines Inc. (NYSE: DAL) reported its third-quarter 2024 earnings report, and shares initially gapped down in reaction to the headline numbers.NYSE:DALNASDAQ:CRWDNASDAQ:AALRead Delta Air Lines: 3 Reasons This Dip Is Too Good to MissOctober 14, 2024 5:45 AM ET3 Stocks Under $20 for Buy-and-Hold Investors Seeking GrowthNathan ReiffBuy-and-hold investors look to firms with strong underlying structures and metrics in the hopes that they will grow; Enovix, Innodata, and AT&T are candidates.NASDAQ:ENVXNASDAQ:INODNYSE:TRead 3 Stocks Under $20 for Buy-and-Hold Investors Seeking GrowthOctober 14, 2024 5:30 AM ETBlackRock's Earnings Reveal Market Shift: Why Bonds Are in FavorGabriel Osorio-MazilliA select list of ETFs and stocks give investors the opportunity to replicate what BlackRock, the world's largest asset manager, is now advising its clients NYSE:BLKNYSEARCA:SPYNYSEARCA:GLDRead BlackRock's Earnings Reveal Market Shift: Why Bonds Are in FavorOctober 14, 2024 5:15 AM ETJPMorgan Can Hit New Highs This Year: Here’s WhyThomas HughesJPMorgan Chase Q3 results were better than expected and point to the continuation of long-term trends and high-probability that a new all-time will be set soon.NYSE:JPMRead JPMorgan Can Hit New Highs This Year: Here’s WhyOctober 14, 2024 5:00 AM ETBest Pharma Stocks for Long-Term Investors: Growth and DividendsNathan ReiffBig pharmaceutical firms may lack the potential for rally driven by a breakout drug like small biotechs, but stability and steady growth remain attractive.NYSE:MRKNYSE:JNJNYSE:ABBVRead Best Pharma Stocks for Long-Term Investors: Growth and DividendsOctober 13, 2024 5:15 AM ETWhy Fastenal Stock Could Hit New Highs After Strong Q3 ResultsThomas HughesDividend Aristocrat Fastenal is on track to reclaim its all-time high and potentially set a new one this year as the diversified business model sustains growth.NASDAQ:FASTRead Why Fastenal Stock Could Hit New Highs After Strong Q3 ResultsOctober 13, 2024 5:00 AM ETWhy Eli Lilly Stock Is Soaring—and How It Plans to Stay on TopLeo MillerEli Lilly is the most valuable pharmaceutical company in the world. I believe the company has what it takes to stay there.NYSE:LLYNYSE:JNJNYSE:NVORead Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on TopOctober 12, 2024 5:15 AM ETChina’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?Ryan HassonChina's newly announced stimulus measures have sparked a significant rally in EV stocks, with XPeng, Li Auto, and NIO seeing notable gains.NYSE:NIONYSE:XPEVNASDAQ:LIRead China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?October 12, 2024 5:15 AM ET3 Mid-Cap Stocks Under $20 With Insider Buying and Major UpsideChris MarkochThese three undervalued mid-cap stocks combine a price below $20 and heavy insider buying; that's a formula for impressive gainsNYSE:RIGNYSE:CRGYNASDAQ:MBLYRead 3 Mid-Cap Stocks Under $20 With Insider Buying and Major UpsideOctober 11, 2024 7:28 AM ET3 Micro-Caps Set for Major Moves: Balancing Risk and OpportunityLeo MillerCheck out these three micro-cap stocks that show big-time potential upside, but also pose face large obstacles to achieving success.NYSEARCA:IWCNYSEARCA:SPYNYSE:AMPXRead 3 Micro-Caps Set for Major Moves: Balancing Risk and OpportunityOctober 11, 2024 7:11 AM ETAutodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?Leo MillerAutodesk was recently named a "top pick" by analysts at Morgan Stanley. So, does this designation make this stock a buy?NASDAQ:ADSKRead Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?October 11, 2024 7:01 AM ET4 Quirky ETFs With Big Potential for Impressive GainsNathan ReiffA growing number of ETFs have niche themes ranging from religious focuses to the mandate to copy particular investors, among many others.NYSEARCA:SPYNASDAQ:QQQNYSEARCA:VTRead 4 Quirky ETFs With Big Potential for Impressive GainsOctober 11, 2024 6:45 AM ET2 Top Stocks Seeing Major Institutional Buying Right NowGabriel Osorio-Mazilli13-F filings are out to show investors where the smart money is flowing into, two stocks stand out in upside potential for the coming quartersNYSE:OXYNASDAQ:FSLRNASDAQ:AAPLRead 2 Top Stocks Seeing Major Institutional Buying Right NowOctober 11, 2024 6:00 AM ETS&P 500 Hits Record Highs: 3 Stocks With Huge Growth PotentialGabriel Osorio-MazilliThree stocks offer significant upside in the coming quarters as they have fallen behind the S&P 500 and its new all-time high, creating a gap to closeNYSE:OXYNYSE:RIGNASDAQ:SOFIRead S&P 500 Hits Record Highs: 3 Stocks With Huge Growth PotentialOctober 11, 2024 5:45 AM ETAbbVie Stock Eyes New Highs: Analysts See Strong Growth PotentialThomas HughesAbbVie is tracking for a new high that may be reached before the end of the year. Acquisitions fuel the growth outlook, cash flow and capital returns.NYSE:ABBVRead AbbVie Stock Eyes New Highs: Analysts See Strong Growth PotentialOctober 11, 2024 5:30 AM ETAZZ Stock Gains Momentum: Analysts Forecast 25% Upside From HereThomas HughesSmall-cap industrial services company AZZ Inc. is on track to extend its trend and rise by another double-digit amount this year. NYSE:AZZRead AZZ Stock Gains Momentum: Analysts Forecast 25% Upside From HereOctober 11, 2024 5:15 AM ETVolatility in Applied Digital May Create an Entry OpportunityChris MarkochApplied Digital stock is showing volatile price action after a positive earnings report but this may create an opportunity for patient investorsNASDAQ:APLDNASDAQ:NVDARead Volatility in Applied Digital May Create an Entry OpportunityOctober 11, 2024 5:00 AM ETDelta’s Earnings Miss? Wall Street Calls It a Buy OpportunityGabriel Osorio-MazilliDelta Airlines has just reported a strong quarter, which might have been even better if it wasn't for the CrowdStrike outages, now Wall Street is bullish NASDAQ:CRWDNASDAQ:UALNYSE:DALRead Delta’s Earnings Miss? Wall Street Calls It a Buy OpportunityOctober 10, 2024 9:23 AM ETMercadoLibre Targets Double-Digit Upside with Argentina BoomGabriel Osorio-MazilliArgentina's economic breakout is giving MercadoLibre shareholders another reason to take a look at the stock, as there is a potential EPS beat in the worksNASDAQ:MELINYSE:BABANASDAQ:AMZNRead MercadoLibre Targets Double-Digit Upside with Argentina BoomOctober 10, 2024 9:21 AM ETDomino’s Pizza Stock Delivers: A Hot Buy for Growth InvestorsThomas HughesDomino's Pizza delivered a mixed result for Q3 and trimmed its revenue guidance. The critical tail is that margin strength is present, providing ample cash.NYSE:DPZRead Domino’s Pizza Stock Delivers: A Hot Buy for Growth InvestorsOctober 10, 2024 9:12 AM ET3 Small-Cap Stocks Ready to Deliver Significant GrowthNathan ReiffSmall-cap firms will have an easier time borrowing money for growth in a lower-interest-rate environment; these are a few companies poised for a breakout.NASDAQ:TZOONYSE:FBRTNASDAQ:AURARead 3 Small-Cap Stocks Ready to Deliver Significant GrowthOctober 10, 2024 8:08 AM ETTop 2 Analyst Picks: Stocks Poised for Double-Digit GrowthThomas HughesChewy, Inc. and Gitlab have growing support from analysts and upward revision trends to support their price action in 2025. NASDAQ:GTLBNYSE:CHWYRead Top 2 Analyst Picks: Stocks Poised for Double-Digit GrowthOctober 10, 2024 7:45 AM ETThese 3 Stocks Are Screaming Oversold: Seize the OpportunityRyan HassonMicron, Biogen, and Regeneron are three stocks that appear oversold and could present substantial buying opportunities for investors seeking recovery plays.NASDAQ:MUNASDAQ:REGNNASDAQ:BIIBRead These 3 Stocks Are Screaming Oversold: Seize the Opportunity Page 13 of 62 « Most Recent‹ More Recent10111213141516 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
